PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastroesophageal reflux disease |
| Phenotype | C0017168|esophageal reflux |
| Sentences | 44 |
| PubMedID- 20838342 | The clinical consequence is rebound acid secretion which may induce dyspeptic symptoms in healthy individuals and exacerbate reflux symptoms in patients with gastroesophageal reflux disease. |
| PubMedID- 23589144 | In patients who were referred for the evaluation of potential association of extraesophageal reflux symptoms with gerd, to exclude or to confirm gerd as a cause of symptoms, ph-mii monitoring was performed off ppi therapy. |
| PubMedID- 23875101 | The aims of this study were to determine whether obesity is associated with gastroesophageal reflux in patients with gastroesophageal reflux disease and to identify the factors affecting increased acid exposure in obese patients. |
| PubMedID- 24676289 | Influence of exercise testing in gastroesophageal reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 23857711 | Objectives/hypothesis: ambulatory esophageal impedance monitoring is commonly employed to assess for nonacid reflux in patients with extraesophageal reflux. |
| PubMedID- 23350046 | Transient les relaxation (tlesr) with volume reflux is considered to be a major mechanism of symptomatic gastroesophageal reflux in patients with gastroesophageal reflux disease (gerd).8-10 during volume reflux, the entire surface of the distal esophagus is thought to be exposed to gastric acid. |
| PubMedID- 21675271 | Aim: to study informative value of 24-h ph monitoring in registration of gastroesophageal and duodenogastroesophageal reflux (ger, dger) in patients with gastroesophageal reflux disease (gerd) before and after surgical treatment. |
| PubMedID- 23128301 | Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy. |
| PubMedID- 21602991 | Conclusions: nocturnal weakly acidic reflux is as common as acid reflux in patients with gastroesophageal reflux disease, and predominates later in the night. |
| PubMedID- 23721547 | Background: arbaclofen placarbil is a pro-drug of the gamma-aminobutyric acid-b agonist r-baclofen that has been shown to reduce reflux episodes in patients with gastro-oesophageal reflux disease (gerd). |
| PubMedID- 25587615 | Autofluorescence imaging endoscopy for predicting acid reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 23669304 | An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 22837877 | Not all reflux episodes occurring in patients with gastroesophageal reflux disease (gerd) are accompanied by reflux symptoms. |
| PubMedID- 20040914 | Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 25881023 | It has been demonstrated that among healthy volunteers weak peristalsis of the esophageal body has predicted incomplete bolus clearance [26] and might account for delayed bolus transit and impaired esophageal reflux clearance in patients with gerd [27,28]. |
| PubMedID- PMC4070603 | But we did not find any correlation between reflux symptom index with gastroesophageal reflux as los angeles classification. |
| PubMedID- 26200333 | Objective: twenty-four-hour multichannel intraluminal impedance (mii) and ph monitoring is used for detecting reflux episodes in patients with gastroesophageal reflux (ger) disease. |
| PubMedID- 24503361 | Detection of acid and nonacid reflux using esophageal reflux monitoring, which includes conventional and wireless ph monitoring and ph impedance, can be a valuable diagnostic tool when used appropriately in the assessment of patients with gastroesophageal reflux disease. |
| PubMedID- 25267601 | Objectives/hypothesis: the association between extraesophageal reflux (eer) and symptoms of gastroesophageal reflux disease (gerd) is inadequately understood. |
| PubMedID- 21459504 | The previous paradigm of airway reflux as synonymous with the classic gastro-oesophageal reflux disease (gord) causing heartburn has been overturned. |
| PubMedID- 26527975 | Thus, the dental erosion prevalence in patients with gastro-esophageal reflux was 35% of all patients with gerd, as shown in fig. |
| PubMedID- 21822428 | The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease. |
| PubMedID- 25847137 | Validated questionnaires such as gastroesophageal reflux disease health-related quality of life (gerd-hrql), reflux symptom index (rsi) and achalasia disease-specific health-related quality of life were obtained pre- and postoperatively. |
| PubMedID- 25965137 | Multiple new endoluminal devices and therapies have been devised to create a more effective antireflux barrier in patients with gastroesophageal reflux disease (gerd). |
| PubMedID- 26123332 | Methods and procedures: data on all patients undergoing poem were collected prospectively between august 2012 and june 2014 and included demographics, objective testing (48-h ph probe, manometry, endoscopy), as well as gastroesophageal reflux disease health-related quality of life (gerd-hrql), gerd symptom scale (gerss), and antacid use. |
| PubMedID- 22046769 | The pathological gastroesophageal reflux disease may lead to the gastroesophageal reflux disease (gerd), manifested as a spectrum of conditions including erosive esophagitis, barrett esophagus and has been linked to the development of adenocarcinoma of the esophagus. |
| PubMedID- 24759350 | Its principle is similar to the controlled delivery of rf energy to the lower oesophageal sphincter region (the stretta procedure), which was proposed as an alternative to standard anti-reflux surgery in patients with gastro-oesophageal reflux disease. |
| PubMedID- 24557959 | Conclusion: speed of food intake has no significant impact on acidic reflux attacks in patients with gastroesophageal reflux disease. |
| PubMedID- 24941823 | Objective: to investigate the association between esophageal motility and acid reflux in patients with gastroesophageal reflux disease (gerd). |
| PubMedID- 25452843 | Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease. |
| PubMedID- 22629750 | The article presents research data of duodenogastral reflux (dgr) role in patients with gastroesophageal reflux disease. |
| PubMedID- 24533836 | The gastric accommodation response to meal intake determines the occurrence of transient lower esophageal sphincter relaxations and reflux events in patients with gastro-esophageal reflux disease. |
| PubMedID- 23158520 | To investigate the relationship between sleep/wakefulness and refluxes 45 newborns with gastroesophageal reflux symptoms were studied with combined multichannel intraluminal impedance and ph monitoring. |
| PubMedID- 24347282 | Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (gerd): a prospective, multicenter, post-marketing observational study. |
| PubMedID- 21369488 | Upper endoscopy and ambulatory ph monitoring were used to diagnose reflux in patients with atypical gastroesophageal reflux symptoms, however, these studies have been proved to have poor diagnostic yield. |
| PubMedID- 23483833 | The diagnostic process is further complicated by the lack of a definitive test for identifying gerd as the cause of extraesophageal reflux symptoms. |
| PubMedID- 22862140 | Small volume acid reflux in gastroesophageal reflux disease patients with hiatal hernia is only detectable by ph-metry but not by multichannel intraluminal impedance. |
| PubMedID- 21320138 | Randomised clinical trial: effects of monotherapy with adx10059, a mglur5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease. |
| PubMedID- 25407279 | Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study. |
| PubMedID- 25172606 | Gastrointestinal symptoms were evaluated with gastroesophageal reflux disease-health related quality of life (gerd-hrql) questionnaire and gastrointestinal symptom rating scale (gsrs), eating behavior with three-factor eating questionnaire before and one year after rygb. |
| PubMedID- 24481258 | Most physician respondents (79.2%) reported that they would treat chronic hoarseness with reflux medication in a patient without evidence of gastroesophageal reflux disease. |
| PubMedID- 24502186 | Introduction: treatment of persistence to proton pump inhibitors or non-acid reflux episodes in patients with gastroesophageal reflux disease is challenging. |
| PubMedID- 25392612 | The gastroesophageal reflux disease–health-related quality of life scale (gerd-hrql) was used to assess the severity of reflux.14 the gerd-hrql is a disease-specific, 10-question, 6-point likert-type scale identifying symptoms such as heartburn and bloating. |
| PubMedID- 21402616 | Objective: o evaluate the efficacy and tolerability of add-on treatment with lesogaberan (azd3355), a novel reflux inhibitor, in patients with persistent gastro-oesophageal reflux disease (gord) symptoms despite proton pump inhibitor (ppi) therapy. |
Page: 1